Unknown

Dataset Information

0

Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-?B pathway activation through RPS3.


ABSTRACT: Chemoresistance is a major cause of cancer progression and the mortality of cancer patients. Developing a safe strategy for enhancing chemosensitivity is a challenge for biomedical science. Recent studies have suggested that vitamin D supplementation may decrease the risk of many cancers. However, the role of vitamin D in chemotherapy remains unknown. We found that vitamin D sensitised oral cancer cells to cisplatin and partially reversed cisplatin resistance. Using RNA-seq, we discovered that lipocalin 2 (LCN2) is an important mediator. Cisplatin enhanced the expression of LCN2 by decreasing methylation at the promoter, whereas vitamin D enhanced methylation and thereby inhibited the expression of LCN2. Overexpression of LCN2 increased cell survival and cisplatin resistance both in vitro and in vivo. High LCN2 expression was positively associated with differentiation, lymph node metastasis, and T staging and predicted a poor prognosis in oral squamous cell carcinoma (OSCC) patients. LCN2 was also associated with post-chemotherapy recurrence. Moreover, we found that LCN2 promoted the activation of NF-?B by binding to ribosomal protein S3 (RPS3) and enhanced the interaction between RPS3 and p65. Our study reveals that vitamin D can enhance cisplatin chemotherapy and suggests that vitamin D should be supplied during chemotherapy; however, more follow-up clinical studies are needed.

SUBMITTER: Huang Z 

PROVIDER: S-EPMC6901542 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3.

Huang Zixian Z   Zhang Yin Y   Li Haigang H   Zhou Yufeng Y   Zhang Qianyu Q   Chen Rui R   Jin Tingting T   Hu Kaishun K   Li Shihao S   Wang Yan Y   Chen Weiliang W   Huang Zhiquan Z  

Cell death & disease 20191209 12


Chemoresistance is a major cause of cancer progression and the mortality of cancer patients. Developing a safe strategy for enhancing chemosensitivity is a challenge for biomedical science. Recent studies have suggested that vitamin D supplementation may decrease the risk of many cancers. However, the role of vitamin D in chemotherapy remains unknown. We found that vitamin D sensitised oral cancer cells to cisplatin and partially reversed cisplatin resistance. Using RNA-seq, we discovered that l  ...[more]

Similar Datasets

| S-EPMC8936515 | biostudies-literature
| S-EPMC10314935 | biostudies-literature
| S-EPMC8683481 | biostudies-literature
| S-EPMC7299958 | biostudies-literature
| S-EPMC10465862 | biostudies-literature
| S-EPMC8375079 | biostudies-literature
| S-EPMC8460061 | biostudies-literature
| S-EPMC4655178 | biostudies-literature
| S-EPMC5520926 | biostudies-literature
| S-EPMC3251881 | biostudies-literature